.Pharmacolibrary.Drugs.R_RespiratorySystem.R05F_CoughSuppressantsAndExpectorantsCombinations.R05FB01_Carbocisteine.Carbocisteine .Pharmacolibrary.Drugs.R_RespiratorySystem.R05F_CoughSuppressantsAndExpectorantsCombinations.R05FB01_Carbocisteine.Carbocisteine| name: | Carbocisteine | |
| ATC code: | R05FB01 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 750 | mg |
| volume of distribution: | 0.41 | L |
| clearance: | 0.13 | L/h/kg |
| other parameters in model implementation | ||
Carbocisteine is a mucolytic agent used for the treatment of chronic obstructive pulmonary disease (COPD), bronchitis, and other respiratory tract disorders where mucus hypersecretion is a problem. It acts by reducing viscosity of mucus and facilitating its expectoration. It is approved for use in several countries, especially in Europe and Asia, but is not FDA-approved in the United States.
Pharmacokinetic parameters in healthy adult volunteers after single oral administration.